Literature DB >> 19188660

Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells.

Bi Tang1, Yingji Li, Chandran Nagaraj, Rory E Morty, Sabine Gabor, Elvira Stacher, Robert Voswinckel, Norbert Weissmann, Katharina Leithner, Horst Olschewski, Andrea Olschewski.   

Abstract

Endothelin (ET)-1 causes long-lasting vasoconstriction and vascular remodeling by interacting with specific G-protein-coupled receptors in pulmonary artery smooth muscle cells (PASMCs), and thus plays an important role in the pathophysiology of pulmonary arterial hypertension. The two-pore domain K(+) channel, TASK-1, controls the resting membrane potential in human PASMCs (hPASMCs), and renders these cells sensitive to a variety of vasoactive factors, as previously shown. ET-1 may exert its vasoconstrictive effects in part by targeting TASK-1. To clarify this, we analyzed the ET-1 signaling pathway related to TASK-1 in primary hPASMCs. We employed the whole-cell patch-clamp technique combined with TASK-1 small interfering RNA (siRNA) in hPASMC and the isolated, perfused, and ventilated mouse lung model. We found that ET-1 depolarized primary hPASMCs by phosphorylating TASK-1 at clinically relevant concentrations. The ET sensitivity of TASK-1 required ET(A) receptors, phospholipase C, phosphatidylinositol 4,5-biphosphate, diacylglycerol, and protein kinase C in primary hPASMCs. The ET-1 effect on membrane potential and TASK-1 was abrogated using TASK-1 siRNA. This is the first time that the background K(+) channel, TASK-1, has been identified in the ET-1-mediated depolarization in native hPASMC, and might represent a novel pathologic mechanism related to pulmonary arterial hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188660     DOI: 10.1165/rcmb.2008-0412OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  22 in total

1.  TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation.

Authors:  C Seyler; E Duthil-Straub; E Zitron; J Gierten; E P Scholz; R H A Fink; C A Karle; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Endothelial dysfunction and blood pressure alterations in K+-channel transgenic mice.

Authors:  Ralf Köhler; Peter Ruth
Journal:  Pflugers Arch       Date:  2010-03-28       Impact factor: 3.657

Review 3.  Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.

Authors:  M Borsotto; J Veyssiere; H Moha Ou Maati; C Devader; J Mazella; C Heurteaux
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

Review 4.  Molecular aspects of structure, gating, and physiology of pH-sensitive background K2P and Kir K+-transport channels.

Authors:  Francisco V Sepúlveda; L Pablo Cid; Jacques Teulon; María Isabel Niemeyer
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 5.  Much more than a leak: structure and function of K₂p-channels.

Authors:  Vijay Renigunta; Günter Schlichthörl; Jürgen Daut
Journal:  Pflugers Arch       Date:  2015-03-21       Impact factor: 3.657

6.  The acid-sensitive, anesthetic-activated potassium leak channel, KCNK3, is regulated by 14-3-3β-dependent, protein kinase C (PKC)-mediated endocytic trafficking.

Authors:  Luke Gabriel; Anatoli Lvov; Demetra Orthodoxou; Ann R Rittenhouse; William R Kobertz; Haley E Melikian
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

7.  Reactive oxygen species scavengers improve voltage-gated K(+) channel function in pulmonary arteries of newborn pigs with progressive hypoxia-induced pulmonary hypertension.

Authors:  Candice D Fike; Judy L Aschner; Mark R Kaplowitz; Yongmei Zhang; Jane A Madden
Journal:  Pulm Circ       Date:  2013-11-20       Impact factor: 3.017

8.  A novel channelopathy in pulmonary arterial hypertension.

Authors:  Lijiang Ma; Danilo Roman-Campos; Eric D Austin; Mélanie Eyries; Kevin S Sampson; Florent Soubrier; Marine Germain; David-Alexandre Trégouët; Alain Borczuk; Erika Berman Rosenzweig; Barbara Girerd; David Montani; Marc Humbert; James E Loyd; Robert S Kass; Wendy K Chung
Journal:  N Engl J Med       Date:  2013-07-25       Impact factor: 91.245

Review 9.  Molecular pathogenesis and current pathology of pulmonary hypertension.

Authors:  Vinicio A de Jesus Perez
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

10.  Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffold.

Authors:  Daniel P Flaherty; Denise S Simpson; Melissa Miller; Brooks E Maki; Beiyan Zou; Jie Shi; Meng Wu; Owen B McManus; Jeffrey Aubé; Min Li; Jennifer E Golden
Journal:  Bioorg Med Chem Lett       Date:  2014-06-19       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.